Latest filing published 28 Mar 2022 for 압타바이오.
서종남: trading record in brief
서종남 is a declared insider of 압타바이오, with filings sourced from DART (FSS). Between 11 August 2020 and 25 August 2021, the trades on record add up to 3 filings.
Purchases make up the whole of the open-market record (2 purchases). The totals do not cover 2 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2022 to date brings 2 purchases and no sales.
The record was last updated on 28 March 2022 with an open-market purchase in 압타바이오. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Companies and markets linked to 서종남
Open company profiles for insider transactions, fundamentals and analyst consensus when available.